In pulmonary arterial hypertension (PAH), chemerin-9, a ChemR23 agonist, promotes intrapulmonary artery contraction by upregulating ChemR23 expression in VSMC [83]. Here, CMKLR1 is linked to pulmonary arterial hypertension.